Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Mettler-Toledo International, Inc. (MTD) vs Revvity Inc. (RVTY)

Mettler-Toledo International, Inc. and Revvity Inc. are both Diagnostics & Research companies. Mettler-Toledo International, Inc. is the larger, with a market value of $30.4B against $16.8B — 1.8× the size. Mettler-Toledo International, Inc. trades at the lower P/E: 33.9× against 72.0×. Mettler-Toledo International, Inc. grew revenue faster over the last twelve months: 6.91% against 4.05%. Mettler-Toledo International, Inc. has the higher net margin (21.9% vs 8.16%) and the higher return on invested capital (35.4% vs 2.38%). Across the 22 metrics below, Mettler-Toledo International, Inc. leads on 13 and Revvity Inc. on 9.

Valuation

Metric MTD RVTY Diagnostics & Research median
P/E 33.94 71.96 33.95
P/S 7.36 5.79 4.87
P/B 2,372.01 2.33 3.12
Price to free cash flow 35.21 29.84 34.02
EV/EBITDA 24.88 24.55 25.20
EV/Sales 7.86 6.54 5.66
Earnings yield 2.95% 1.39% (1.75%)
Free cash flow yield 2.84% 3.35% (0.13%)

Profitability

Metric MTD RVTY Diagnostics & Research median
Gross margin 60.26% 54.98% 50.89%
Operating margin 28.41% 12.32% (8.57%)
Net margin 21.91% 8.16% (6.37%)
Free cash flow margin 20.90% 19.58% 0.00%
Return on equity (736.36%) 3.21% (2.92%)
Return on assets 25.61% 1.95% (6.71%)
Return on invested capital 35.40% 2.38% 0.00%

Growth

Metric MTD RVTY Diagnostics & Research median
Revenue growth (TTM) 6.91% 4.05% 7.69%
EPS growth (last fiscal year) 3.88% (5.91%) —
Revenue growth, 5-year CAGR 5.47% 1.41% 7.40%
Net income growth, 5-year CAGR 7.60% (19.82%) 0.00%

Health

Metric MTD RVTY Diagnostics & Research median
Debt to equity 164.70 0.44 0.11
Current ratio 1.12 1.80 2.02
Net debt to EBITDA 1.68 3.00 0.78

Dividend

Metric MTD RVTY Diagnostics & Research median
Dividend yield — 0.27% 0.70%
Payout ratio 0.00 0.05 0.00

Size

Metric MTD RVTY Diagnostics & Research median
Market cap 30.44b 16.81b 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack